{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:34:16Z","timestamp":1793100856376,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Real-world vaccine effectiveness (VE) has increasingly been studied using matching-based approaches, particularly in observational cohort studies that follow the target trial emulation framework. Although matching is appealing in its simplicity, it has important limitations in terms of clarity of the target estimand and the precision with which it is estimated. Moreover, defining causal estimands of VE requires care, because vaccine uptake often occurs over calendar time when infection dynamics may also be rapidly changing. We propose a causal estimand of VE that summarizes VE over calendar time, similar to how vaccine efficacy is summarized in randomized controlled trials. We describe the identification of our estimand and propose simple-to-implement estimators based on two hazard regression models. We apply our proposed estimator in simulations and in a study assessing the effectiveness of the Pfizer-BioNTech COVID-19 vaccine to prevent SARS-CoV-2 infections in children 5\u201311 years old. In both settings, we find that our proposed estimator yields similar scientific inferences while providing significant efficiency gains over commonly used matching-based estimators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001982","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:07:29Z","timestamp":1774894049000},"page":"612-619","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Target Trial Emulation Without Matching: A More Efficient Approach for Evaluating Vaccine Effectiveness Using Observational Data"],"prefix":"10.1097","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5487-6753","authenticated-orcid":false,"given":"Emily","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-3747","authenticated-orcid":false,"given":"Elizabeth","family":"Rogawski McQuade","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-1936","authenticated-orcid":false,"given":"Mats J.","family":"Stensrud","sequence":"additional","affiliation":[{"name":"Department of Mathematics, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Nabi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-8343","authenticated-orcid":false,"given":"David","family":"Benkeser","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"R1-20261027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R2-20261027","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R3-20261027","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1093\/aje\/kwaf053","article-title":"Exploring the application of target trial emulation in vaccine evaluation: scoping review.","volume":"194","author":"Komura","year":"2025","journal-title":"Am J Epidemiol"},{"key":"R4-20261027","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting.","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20261027","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"R6-20261027","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMc2114290","article-title":"Effectiveness of BNT162b2 vaccine against delta variant in adolescents.","volume":"385","author":"Reis","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20261027","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/M21-3256","article-title":"COVID-19 vaccination effectiveness against infection or death in a national U.S. health care system.","volume":"175","author":"Ioannou","year":"2022","journal-title":"Ann Intern Med"},{"key":"R8-20261027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa2205011","article-title":"BNT162b2 vaccine effectiveness against Omicron in children 5 to 11 years of age.","volume":"387","author":"Cohen-Stavi","year":"2022","journal-title":"N Engl J Med"},{"key":"R9-20261027","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1093\/cid\/ciac429","article-title":"Effectiveness of a second dose of an mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron infection in individuals previously infected by other variants.","volume":"76","author":"Monge","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R10-20261027","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/M21-4269","article-title":"Challenges in estimating the effectiveness of COVID-19 vaccination using observational data.","volume":"176","author":"Hulme","year":"2023","journal-title":"Ann Intern Med"},{"key":"R11-20261027","doi-asserted-by":"crossref","first-page":"eadj3747","DOI":"10.1126\/sciadv.adj3747","article-title":"Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: a review and case study.","volume":"9","author":"Meah","year":"2023","journal-title":"Sci Adv"},{"key":"R12-20261027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/EDE.0000000000001628","article-title":"The prevalent new-user design for studies with no active comparator: the example of statins and cancer.","volume":"34","author":"Suissa","year":"2023","journal-title":"Epidemiology"},{"key":"R13-20261027","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1097\/EDE.0000000000001667","article-title":"Re: Are target trial emulations the gold standard for observational studies?","volume":"35","author":"Didelez","year":"2024","journal-title":"Epidemiology"},{"key":"R14-20261027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jclinepi.2023.08.003","article-title":"The implementation of target trial emulation for causal inference: a scoping review.","volume":"162","author":"Zuo","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"R15-20261027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12874-023-02000-9","article-title":"Implementation of the trial emulation approach in medical research: a scoping review.","volume":"23","author":"Scola","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"R16-20261027","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","article-title":"Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative.","volume":"143","author":"Franklin","year":"2021","journal-title":"Circulation"},{"key":"R17-20261027","doi-asserted-by":"crossref","first-page":"e049540","DOI":"10.1136\/bmjopen-2021-049540","article-title":"Development of chronic kidney disease influenced by serum urate and body mass index based on young-to-middle-aged Japanese men: a propensity score-matched cohort study.","volume":"12","author":"Kuma","year":"2022","journal-title":"BMJ Open"},{"key":"R18-20261027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/oxfordjournals.aje.a115469","article-title":"Matching and efficiency in cohort studies.","volume":"131","author":"Greenland","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R19-20261027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwp436","article-title":"Invited commentary: positivity in practice.","volume":"171","author":"Westreich","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R20-20261027","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2188\/jea.JE20210145","article-title":"Using propensity scores for causal inference: pitfalls and tips.","volume":"31","author":"Shiba","year":"2021","journal-title":"J Epidemiol"},{"key":"R21-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward.","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"R24-20261027","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/sim.9718","article-title":"Causal inference in survival analysis using longitudinal observational data: sequential trials and marginal structural models.","volume":"42","author":"Keogh","year":"2023","journal-title":"Stat Med"},{"key":"R25-20261027","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/EDE.0000000000001637","article-title":"Start with the target trial protocol, then follow the roadmap for causal inference.","volume":"34","author":"Dang","year":"2023","journal-title":"Epidemiology"},{"key":"R26-20261027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"R27-20261027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1191\/0962280204sm356ra","article-title":"Endpoints in vaccine trials.","volume":"13","author":"Hudgens","year":"2004","journal-title":"Stat Methods Med Res"},{"key":"R28-20261027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M20-6169","article-title":"Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials.","volume":"174","author":"Mehrotra","year":"2021","journal-title":"Ann Intern Med"},{"key":"R29-20261027","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1214\/17-AOAS1095","article-title":"Design of vaccine trials during outbreaks with and without a delayed vaccination comparator.","volume":"12","author":"Dean","year":"2018","journal-title":"Ann Appl Stat"},{"key":"R30-20261027","doi-asserted-by":"crossref","first-page":"eaat0360","DOI":"10.1126\/scitranslmed.aat0360","article-title":"Design of vaccine efficacy trials during public health emergencies.","volume":"11","author":"Dean","year":"2019","journal-title":"Sci Transl Med"},{"key":"R31-20261027","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/19466315.2023.2211538","article-title":"Vaccine development during a pandemic: general lessons for clinical trial design.","volume":"16","author":"Hofner","year":"2024","journal-title":"Stat Biopharm Res"},{"key":"R32-20261027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0006-341X.2002.00021.x","article-title":"Principal stratification in causal inference.","volume":"58","author":"Frangakis","year":"2002","journal-title":"Biometrics"},{"key":"R33-20261027","first-page":"2060","article-title":"Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.","volume":"45","author":"Lipsitch","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R34-20261027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jep.13839","article-title":"Sources of bias in observational studies of COVID-19 vaccine effectiveness.","volume":"30","author":"Fung","year":"2024","journal-title":"J Eval Clin Pract"},{"key":"R35-20261027","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"key":"R36-20261027","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa2117128","article-title":"Effectiveness of COVID-19 vaccines over a 9-month period in North Carolina.","volume":"386","author":"Lin","year":"2022","journal-title":"N Engl J Med"},{"key":"R37-20261027","doi-asserted-by":"crossref","first-page":"e2245417","DOI":"10.1001\/jamanetworkopen.2022.45417","article-title":"Infections, hospitalizations, and deaths among US nursing home residents with vs without a SARS-CoV-2 vaccine booster.","volume":"5","author":"McConeghy","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R38-20261027","article-title":"Assessing COVID-19 vaccine effectiveness in observational studies via nested trial emulation.","author":"DeMonte","year":"2024","journal-title":"arXiv preprint arXiv:2403.18115"},{"key":"R39-20261027","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/EDE.0000000000001636","article-title":"Are target trial emulations the gold standard for observational studies?","volume":"34","author":"Pearce","year":"2023","journal-title":"Epidemiology"},{"key":"R40-20261027","doi-asserted-by":"crossref","first-page":"e222959","DOI":"10.1001\/jamanetworkopen.2022.2959","article-title":"Durability of the single-dose Ad26.COV2.S vaccine in the prevention of COVID-19 infections and hospitalizations in the US before and during the delta variant surge.","volume":"5","author":"Polinski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R41-20261027","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.7326\/M22-1856","article-title":"Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization, and death: a target trial emulation in the omicron (B.1.1.529) variant era.","volume":"175","author":"Ioannou","year":"2022","journal-title":"Ann Intern Med"},{"key":"R42-20261027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M21-4130","article-title":"The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine.","volume":"175","author":"Gazit","year":"2022","journal-title":"Ann Intern Med"},{"key":"R43-20261027","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/sim.5879","article-title":"Ignoring the matching variables in cohort studies \u2013 when is it valid and why?","volume":"32","author":"Sj\u00f6lander","year":"2013","journal-title":"Stat Med"},{"key":"R44-20261027","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ije\/dyt083","article-title":"Matched designs and causal diagrams.","volume":"42","author":"Mansournia","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R45-20261027","first-page":"591","article-title":"Randomization analysis of experimental data: the Fisher randomization test comment.","volume":"75","author":"Rubin","year":"1980","journal-title":"J Am Stat Assoc"},{"key":"R46-20261027","doi-asserted-by":"crossref","first-page":"127292","DOI":"10.1016\/j.vaccine.2025.127292","article-title":"Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program.","volume":"61","author":"Harton","year":"2025","journal-title":"Vaccine"},{"key":"R47-20261027","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.","volume":"15","author":"Ho","year":"2007","journal-title":"Political Analysis"},{"key":"R48-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pan\/mpr013","article-title":"Causal inference without balance checking: coarsened exact matching.","volume":"20","author":"Iacus","year":"2012","journal-title":"Political Analysis"},{"key":"R49-20261027","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/0962280219887196","article-title":"Performance of propensity score matching to estimate causal effects in small samples.","volume":"29","author":"Andrillon","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"R50-20261027","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1016\/j.vaccine.2023.07.065","article-title":"Impact of CoronaVac on COVID-19 outcomes of elderly adults in a large and socially unequal Brazilian city: a target trial emulation study.","volume":"41","author":"Monteiro","year":"2023","journal-title":"Vaccine"},{"key":"R51-20261027","article-title":"Time-lag bias induced by unobserved heterogeneity: comparing treated patients to controls with a different start of follow-up.","author":"van Eekelen","year":"2024","journal-title":"arXiv preprint arXiv:2105.07685"},{"key":"R52-20261027","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1198\/016214508000000292","article-title":"Toward causal inference with interference.","volume":"103","author":"Hudgens","year":"2008","journal-title":"J Am Stat Assoc"},{"key":"R53-20261027","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40471-016-0086-4","article-title":"Dependent happenings: a recent methodological review.","volume":"3","author":"Halloran","year":"2016","journal-title":"Curr Epidemiol Rep"},{"key":"R54-20261027","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/01621459.2020.1782219","article-title":"Network dependence can lead to spurious associations and invalid inference.","volume":"116","author":"Lee","year":"2021","journal-title":"J Am Stat Assoc"},{"key":"R55-20261027","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/aje\/kwab167","article-title":"Assortativity and bias in epidemiologic studies of contagious outcomes: a simulated example in the context of vaccination.","volume":"190","author":"Zivich","year":"2021","journal-title":"Am J Epidemiol"},{"key":"R56-20261027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12874-025-02611-4","article-title":"Over-and under-estimation of vaccine effectiveness.","volume":"25","author":"De-Leon","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"R57-20261027","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/EDE.0000000000000078","article-title":"Causal models and learning from data: integrating causal modeling and statistical estimation.","volume":"25","author":"Petersen","year":"2014","journal-title":"Epidemiology"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0000000000001982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:00:30Z","timestamp":1793098830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0000000000001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001982","relation":{},"ISSN":["1044-3983","1531-5487"],"issn-type":[{"value":"1044-3983","type":"print"},{"value":"1531-5487","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}